Grifols

GRFSNasdaq Spain Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$5.459 B

$7.94 +1.41%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#56Amneal PharmaceuticalsAMRX$5.79B
#57Travere TherapeuticsTVTX$5.78B
#58GrifolsGRFS$5.46B
#59Acadia PharmaceuticalsACAD$5.03B
#60Dyne TherapeuticsDYN$4.90B

Where these numbers come from

Share counts and financials for Grifols are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.